| Product Code: ETC10602646 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of human papilloma virus vaccines to Portugal in 2024 were primarily sourced from the Netherlands, Spain, USA, Sweden, and the UK. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), increased significantly from 2023 to 2024, indicating a very high concentration of imports within these top exporting countries. Despite a high compound annual growth rate (CAGR) of 56.26% from 2020 to 2024, there was a slight decline in the growth rate from 2023 to 2024 at -4.78%. This data suggests a stable yet concentrated market for HPV vaccine imports in Portugal.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Human Papilloma Virus Vaccine Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Human Papilloma Virus Vaccine Market - Industry Life Cycle |
3.4 Portugal Human Papilloma Virus Vaccine Market - Porter's Five Forces |
3.5 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Age Group Targeted, 2021 & 2031F |
3.7 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.9 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Portugal Human Papilloma Virus Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of HPV vaccination in preventing cervical cancer |
4.2.2 Government initiatives to include HPV vaccination in national immunization programs |
4.2.3 Growing focus on preventive healthcare measures |
4.3 Market Restraints |
4.3.1 High cost associated with HPV vaccines leading to limited accessibility |
4.3.2 Lack of awareness among certain segments of the population about HPV and its related vaccines |
4.3.3 Regulatory challenges and approval processes for HPV vaccines |
5 Portugal Human Papilloma Virus Vaccine Market Trends |
6 Portugal Human Papilloma Virus Vaccine Market, By Types |
6.1 Portugal Human Papilloma Virus Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Quadrivalent Vaccine, 2021 - 2031F |
6.1.4 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Bivalent Vaccine, 2021 - 2031F |
6.2 Portugal Human Papilloma Virus Vaccine Market, By Age Group Targeted |
6.2.1 Overview and Analysis |
6.2.2 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Children/Adolescents, 2021 - 2031F |
6.2.3 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Young Adults, 2021 - 2031F |
6.3 Portugal Human Papilloma Virus Vaccine Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Portugal Human Papilloma Virus Vaccine Market, By Application Area |
6.4.1 Overview and Analysis |
6.4.2 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Cervical Cancer Prevention, 2021 - 2031F |
6.4.3 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By HPV Type 16 & 18 Prevention, 2021 - 2031F |
6.5 Portugal Human Papilloma Virus Vaccine Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By Public Health Programs, 2021 - 2031F |
6.5.3 Portugal Human Papilloma Virus Vaccine Market Revenues & Volume, By School Health Programs, 2021 - 2031F |
7 Portugal Human Papilloma Virus Vaccine Market Import-Export Trade Statistics |
7.1 Portugal Human Papilloma Virus Vaccine Market Export to Major Countries |
7.2 Portugal Human Papilloma Virus Vaccine Market Imports from Major Countries |
8 Portugal Human Papilloma Virus Vaccine Market Key Performance Indicators |
8.1 Percentage increase in HPV vaccination coverage rate among the target population |
8.2 Number of healthcare providers offering HPV vaccination services |
8.3 Rate of adoption of HPV vaccination in school-based immunization programs |
9 Portugal Human Papilloma Virus Vaccine Market - Opportunity Assessment |
9.1 Portugal Human Papilloma Virus Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Portugal Human Papilloma Virus Vaccine Market Opportunity Assessment, By Age Group Targeted, 2021 & 2031F |
9.3 Portugal Human Papilloma Virus Vaccine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Portugal Human Papilloma Virus Vaccine Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.5 Portugal Human Papilloma Virus Vaccine Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Portugal Human Papilloma Virus Vaccine Market - Competitive Landscape |
10.1 Portugal Human Papilloma Virus Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Portugal Human Papilloma Virus Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |